Debucquoy Annelies, Libbrecht Louis, Roobrouck Valerie, Goethals Laurence, McBride William, Haustermans Karin
Department of Radiation Oncology, Leuven Cancer Institute, University Hospital Leuven, Belgium.
Eur J Cancer. 2008 Apr;44(6):791-7. doi: 10.1016/j.ejca.2008.02.023. Epub 2008 Mar 18.
In this study, the prognostic and/or predictive value of different proteins (cyclo-oxygenase 2 (COX-2), Ki67 and cleaved cytokeratin (CK) 18) and fibro-inflammatory changes which might be of importance for the response to treatment were evaluated using tissue micro arrays. Samples were obtained from a subset of 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 clinical trial, which randomised patients with rectal cancer to one of four arms treated with preoperative radiotherapy with or without pre- and/or postoperative chemotherapy. From our results, we can conclude that the addition of preoperative chemotherapy to radiotherapy led to significantly less COX-2 upregulation, less proliferation and more inflammation, as was seen in the resection specimen as well as less invasion and metastasis. For COX-2, Ki67 or cleaved CK18, no predictive or prognostic value could be identified. However, the fibro-inflammatory reaction after preoperative radiochemotherapy correlated with T-downstaging and seems to be an important factor for response.
在本研究中,使用组织微阵列评估了不同蛋白质(环氧化酶2(COX-2)、Ki67和裂解细胞角蛋白(CK)18)的预后和/或预测价值,以及可能对治疗反应具有重要意义的纤维炎症变化。样本取自欧洲癌症研究与治疗组织22921临床试验中纳入的95例患者的一个子集,该试验将直肠癌患者随机分为四个治疗组之一,接受术前放疗加或不加术前和/或术后化疗。从我们的结果可以得出结论,放疗联合术前化疗导致COX-2上调显著减少、增殖减少、炎症增加,这在切除标本中也有体现,同时侵袭和转移减少。对于COX-2、Ki67或裂解CK18,未发现有预测或预后价值。然而,术前放化疗后的纤维炎症反应与肿瘤降期相关,似乎是反应的一个重要因素。